250 -5 (79) 2025 - Nigora B.S. - ASSESSMENT OF THE IMPACT OF BARIATRIC TREATMENT ON THE COURSE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN OBESE PATIENTS

ASSESSMENT OF THE IMPACT OF BARIATRIC TREATMENT ON THE COURSE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN OBESE PATIENTS

Nigora B.S. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Currently, non-alcoholic fatty liver disease (NAFLD) has become a leading condition among chronic liver diseases, accounting for 71.6% of their total cases. Its prevalence is increasing, including among young individuals. This article reviews literature dedicated to bariatric therapy in patients with NAFLD and comorbid obesity, and describes a clinical case as an example of such a condition in a 45-year-old female patient. The effectiveness of a comprehensive approach in a patient with NAFLD and obesity is noted. The presented case demonstrates that laparoscopic gastric banding contributed to weight reduction and positively influenced the course of gastroenterological diseases, improved quality of life, and reduced the risk of exacerbations

Keywords: non-alcoholic fatty liver disease (NAFLD), steatosis, obesity, bariatric treatment

First page

1241

Last page

1246

For citation:Nigora B.S. - ASSESSMENT OF THE IMPACT OF BARIATRIC TREATMENT ON THE COURSE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN OBESE PATIENTS//New Day in Medicine 5(79)2025 1241-1246 https://newdayworldmedicine.com/en/new_day_medicine/5-79-2025

List of References

1. Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6months / A. Keshishian, K. Zahriya, E. B. Willes // Obesity Surg. – 2005. — № 15(10). – Р.1418–1423.
2. Effect of bariatric surgery on liver fibrosis / M. Moretto, C. Kupski, V. D. da Silva [et al.] // Obesity Surg. – 2012. — № 22 (7). — Р.1044–1049.
3. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis / R. R. Mummadi, K. S. Kasturi, S. Chennareddygari, G. K. Sood // Clin. Gastroenterol. Hepatol. – 2008. — № 6 (12). — Р. 1396-402.
4. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis / J. G. Kral, S. N. Thung, S. Biron [et al.] // Surgery. – 2004. — № 135 (1). – Р.48–58.
5. Hafeez S., Ahmed M. H. Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance? // J. Obesity. — 2013. [Электронный ресурс]. Режим доступа: http://www.hindawi.com/journals/jobe/2013/839275/
6. Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease / D. E. Kleiner, E. M. Brunt, M. Van Natta [et al.] // Hepatology. – 2005. – № 41(6). – Р.1313–1321.
7. Prospective study of the long term effects of bariatric surgery on liver injury in patients without advanced disease / P. Mathurin, A Hollebecque., L. Arnalsteen [et al.] // Gastroenterol. — 2009. — № 137 (2). – Р.532–540.
8. Resolution of nonalcoholic steatohepatits after gastric bypass surgery / X. Liu, A. J. Lazenby, R. H. Clements [et al.] // Obesity Surg. – 2007. — № 17 (4). – Р.486– 492.
9. Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity / S.R. de Almeida, P.R.S. Rocha, M.D. Sanches[et al.] // Obesity Surg. – 2006. — № 16 (3). – Р.270–278.
10. Surgically induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome / S. G. Mattar, L. M. Velcu, M. Rabinovitz [et al.] // Ann. Surg. – 2005. — № 242 (4). – Р.610– 620.

    file

    download